Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Blut|August 1, 1986
No evidence of LAV infection in the Republic of Liberia, West Africa, in the year 1973J Neppert, S Göhring, W Schneider, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Procedure for production of leukocyte depleted erythrocyte and thrombocyte concentrates (PRP method) using top and bottom bags, Optipress automated separators and a computer controlled Cryofuge 6000]M Aulmann, R Ullrich, B Iber, et al.
Zeitschrift Fur Hautkrankheiten|June 15, 1980
[Trials with therapeutic plasmapheresis in pemphigus vulgaris]J Neppert, K Meissner, H Voigt, et al.
Blood|February 1, 1986
Receptor patching and capping of platelet membranes induced by monoclonal antibodiesS Santoso, U Zimmermann, J Neppert, et al.
Arzneimittel-Forschung|November 1, 1989
Transfer of metaclazepam and its metabolites into breast milkA Schotter, R Müller, C Günther, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1982
[Pharmacokinetics and biotransformation of N-propylajmaline hydrogen tartrate in man]H J Hausleiter, G Achtert, M A Khan, et al.
Journal of Clinical Laboratory Analysis|January 17, 2002
HLA-antibody testing: the immune phagocytosis inhibition test is superior to the PRA-STAT and NIH lymphocytotoxic test with respect to specificityB K Flesch, M Philipp, U Cassens, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Serologic characterization of granulocyte-specific antibodies in neonatal alloimmune neutropenias]J Bux, K Kissel, J Neppert, et al.
Vox Sanguinis|September 14, 2001
Fcgamma receptor-mediated immune phagocytosis depends on the class of FcgammaR and on the immunoglobulin-coated target cellB K Flesch, K Vöge, T Henrichs, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1986
Pharmacokinetic profile of metaclazepam (Talis), a new 1.4-benzodiazepine. Influence of different dosage regimens on the pharmacokinetic profile of metaclazepam and its main metabolite under steady-state conditionsW Gielsdorf, K H Molz, H J Hausleiter, et al.
Pageof 19